Regeneron Pharmaceuticals (NASDAQ:REGN) mentioned on Monday its bispecific antibody Ordspono (odronextamab) has been cleared by the European Commission for the therapy of relapsed/refractory follicular lymphoma and…
Browsing: cancer
BCFC/iStock Editorial through Getty Images McKesson Corp. (NYSE:MCK) is in superior discussions to acquire a controlling stake in a privately held operator of oncology clinics. Drug…
Roman Didkivskyi Siemens Healthineers (OTCPK:SEMHF) is wanting to pay greater than €200M ($224M) to purchase a Novartis (NYSE:NVS) business targeted on producing radioactive chemical compounds for…
JHVEPhoto BeiGene (NASDAQ:BGNE) has acquired FDA Fast Track Designation for its investigational cancer therapy. BGB-16673, an orally accessible BTK-targeting chimeric degradation activation compound, gained fast track…
Regeneron Pharmaceuticals (NASDAQ:REGN) mentioned on Monday its bispecific antibody Ordspono (odronextamab) has been cleared by the European Commission for the remedy of relapsed/refractory follicular lymphoma and…
Dr_Microbe A U.S. FDA panel of advisors will meet in late September to debate whether or not to restrict using immune checkpoint inhibitors to deal with…
BCFC/iStock Editorial by way of Getty Images McKesson Corp. (NYSE:MCK) is in superior discussions to acquire a controlling stake in a privately held operator of oncology…
Roman Didkivskyi Siemens Healthineers (OTCPK:SEMHF) is wanting to pay greater than €200M ($224M) to purchase a Novartis (NYSE:NVS) business centered on producing radioactive chemical compounds for…
Dr_Microbe A U.S. FDA panel of advisors will meet in late September to debate whether or not to restrict using immune checkpoint inhibitors to deal with…
BCFC/iStock Editorial through Getty Images McKesson Corp. (NYSE:MCK) is in superior discussions to acquire a controlling stake in a privately held operator of oncology clinics. Drug…